EUVIMEDEUVIMED entdecken
Crossref

Gastrodin Ameliorates Blood Pressure by Targeting the PPAR-γ/NF-κB/NLRP3 Signaling Axis in the Hypothalamic Paraventricular Nucleus

Yu Yang, Xiao-Jing Yu, Li-Yan Fu, Jie Qi, Kai-Li Liu, Xiu-Yue Jia, Wei Cui, Qing Su, Ting Huang, Yan-Feng Liang, Hua Tian, Huan Liu und 2 weitere

Cardiovascular Toxicology · 2026

DOI: 10.1007/s12012-026-10139-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Toxicology, 2026. Verfasst von Yu Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, Shaan…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Glucosides, Benzyl Alcohols, PPAR gamma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province, the Open Fund for Key Laboratory of precision medicine for children's diseases in Shaanxi province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension increases the risk for cardiovascular and cerebrovascular diseases and both its preventive and current therapeutics measures require extensive investigations. Despite that Gastrodin, a neuroprotective compound extracted from a Traditional Chinese medicine (TCM), reportedly has preventive and curative potentials in hypertensive patients, its molecular mechanisms in lowering blood pressure still remain obscure. This study was designed to test the hypothesis that gastrodin lowers blood pressure by targeting the PPAR-γ/NF-κB/NLRP3 signaling axis in the hypothalamic paraventricular (PVN). Gastrodin or vehicle (artificial cerebrospinal fluid, aCSF) was directly infused into the PVN through a mini osmotic pump for 28 days to Spontaneous hypertensive rats (SHRs) and Wistar Kyoto (WKY). Four groups of rats were set: WKY + PVN vehicle; WKY + PVN Gastrodin; SHR + PVN vehicle; and SHR + PVN Gastrodin. Blood pressure was monitored and at the conclusion of experiment, plasma and PVN samples were collected and processed for ELISA, PCR, Western blotting and Immunofluorescence analyses. SHRs had elevated blood pressure (BP), heart rate (HR) and plasmatic norepinephrine (NE) validating their hypertensive status. PVN micro-infusion of gastrodin markedly reversed these hypertensive features in SHRs. At molecular level, gastrodin attenuated the local production of reactive oxygen species (ROS), reduced NADPH Oxidases (NOX)2 and NOX4 messenger RNA (mRNA) level and attenuated the activation of PPAR-γ in the PVN. In addition, gastrodin reduced the inflammasome activation and the expression of interleukin-1β (IL-1β). Furthermore, pretreatment with gastrodin reduced the expression of caspase-1 p10 and inflammation (IL-1β and MCP-1), the ratio of phosphorylated kappa B kinase (p-IKK)/IKK, and that of p-p65/p65 in the PVN of SHRs. In conclusion, gastrodin-lowered blood pressure is associated with balanced PPAR-γ/NF-κB/NLRP3 signaling axis within the PVN local highlighting its promising properties in the management of hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinGlucosidesBenzyl AlcoholsPPAR gammaBlood PressureHypertensionParaventricular Hypothalamic NucleusNF-kappa BAntihypertensive AgentsInflammasomesAnti-Inflammatory AgentsAnimalsSignal TransductionRats, Inbred SHRRats, Inbred WKYMaleDisease Models, AnimalReactive Oxygen SpeciesOxidative StressInflammation Mediators

Stichwörter der Autor:innen

GastrodinHypertensionHypothalamic paraventricular nucleusOxidative stressPPAR-γ/NF-κB/NLRP3 signaling axis

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinGlucosidesBenzyl AlcoholsPPAR gammaNlrp3 protein, ratgastrodinNF-kappa BAntihypertensive AgentsPPAR gamma, ratInflammasomes

Autor:innen und Institutionen

  • Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, Shaanxi, China.
  • Institute of Cardiovascular Sciences, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, Shaanxi, China.
  • Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education, Xi'an, 710061, Shaanxi, China.
  • Department of Pharmacology, Basic Medical College, Jiamusi University, Jiamusi, 154007, Heilongjiang, China.
  • College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan, China.
  • Department of Physiology, Basic Medical College, Jiamusi University, Jiamusi, 154007, Heilongjiang, China.

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Projects of Shaanxi Province
  • the Open Fund for Key Laboratory of precision medicine for children's diseases in Shaanxi province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Yang, Y., Yu, X. J., Fu, L. Y., Qi, J., Liu, K. L., Jia, X. Y., Cui, W., Su, Q., Huang, T., Liang, Y. F., Tian, H., Liu, H., Gao, H. L., & Kang, Y. M. (2026). Gastrodin Ameliorates Blood Pressure by Targeting the PPAR-γ/NF-κB/NLRP3 Signaling Axis in the Hypothalamic Paraventricular Nucleus. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-026-10139-2

Vancouver

Yang Y, Yu XJ, Fu LY, Qi J, Liu KL, Jia XY, et al. Gastrodin Ameliorates Blood Pressure by Targeting the PPAR-γ/NF-κB/NLRP3 Signaling Axis in the Hypothalamic Paraventricular Nucleus. Cardiovascular Toxicology. 2026. doi:10.1007/s12012-026-10139-2

BibTeX
@article{Yang2026,
  author = {Yang, Yu and Yu, Xiao-Jing and Fu, Li-Yan and Qi, Jie and Liu, Kai-Li and Jia, Xiu-Yue and Cui, Wei and Su, Qing and Huang, Ting and Liang, Yan-Feng and Tian, Hua and Liu, Huan and Gao, Hong-Li and Kang, Yu-Ming},
  title = {Gastrodin Ameliorates Blood Pressure by Targeting the PPAR-γ/NF-κB/NLRP3 Signaling Axis in the Hypothalamic Paraventricular Nucleus},
  journal = {Cardiovascular Toxicology},
  year = {2026},
  doi = {10.1007/s12012-026-10139-2}
}
Kostenlos starten →